Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;125(6):478-91.
doi: 10.1111/j.1600-0447.2011.01821.x. Epub 2011 Dec 30.

Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback

B J Carroll  1 , A Iranmanesh, D M Keenan, F Cassidy, W H Wilson, J D Veldhuis
Affiliations

Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback

B J Carroll et al. Acta Psychiatr Scand. 2012 Jun.

Abstract

Objective: To test three theories of hypercortisolemia in depression-hypothalamic overdrive, impaired glucocorticoid feedback, or autonomous cortisol production.

Method: We applied an overnight low-cortisol feedback strategy by administering metyrapone to hypercortisolemic depressed in-patients and control subjects.

Results: Under metyrapone, the increases of plasma adrenocorticotropic hormone (ACTH) concentrations and of basal and pulsatile ACTH secretion were not exaggerated in hypercortisolemic depressed patients compared with control subjects. ACTH approximate entropy (ApEn) did not differ at baseline or under metyrapone. Thus, neither hypothalamic overdrive nor irregular ACTH secretion was seen. We did not detect impaired cortisol feedback: the ACTH response was not reduced, and ApEn measures that are sensitive to feedback changes were comparable in both groups. Metyrapone disrupted cortisol secretory regularity in depressed and control subjects. On the baseline day, basal cortisol secretion was significantly increased and was highly irregular (high ApEn), and ACTH-cortisol cross-ApEn was markedly elevated in high-cortisol patients.

Conclusion: Classical feed-forward overdrive and impaired feedback theories of hypercortisolemia in depression were not supported. Depressive hypercortisolemia may result from alternative pathophysiological mechanisms involving irregular basal hypersecretion of cortisol, associated with adrenal enlargement, possibly through splanchnic sympathetic activation of the adrenal cortex.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No part of this work has been previously published or is under consideration for publication elsewhere. The authors have no competing financial interests in relation to this work. In the past 3 years, Dr. Bernard Carroll has received compensation from AstraZeneca, MultiHealth Systems (licensee for the Carroll Depression Scales), South Carolina Psychiatric Association, Springer Publishing Company and Brentwood Biomedical Research Institute, Los Angeles. Dr. Frederick Cassidy has had a grant from Pfizer.

Figures

Figure 1
Figure 1
Median plots in control subjects and high-cortisol depressed patients, showing comparable ACTH A and cortisol levels B at 0200h–0230h when both groups exceeded their Day 1 mean ACTH concentrations under metyrapone.
Figure 1
Figure 1
Median plots in control subjects and high-cortisol depressed patients, showing comparable ACTH A and cortisol levels B at 0200h–0230h when both groups exceeded their Day 1 mean ACTH concentrations under metyrapone.
Figure 2
Figure 2
Detail showing early increase of median ACTH concentrations under metyrapone in control subjects A and high-cortisol depressed patients B.
Figure 2
Figure 2
Detail showing early increase of median ACTH concentrations under metyrapone in control subjects A and high-cortisol depressed patients B.
Figure 3
Figure 3
Bar graphs representing paired (within-subject) comparisons of ACTH secretory changes during metyrapone (M) compared with placebo (P) exposure in the subjects presented in Figure 1. MPP denotes mass per pulse.
Figure 4
Figure 4
Estimates of basal (top) and pulsatile (bottom) ACTH secretion in healthy subjects (N =11), high-cortisol depressed (N=7) and low-cortisol depressed (N=5) patients. Data are the mean ± SEM. The overall ANCOVA model yielded P<0.001. Group, treatment and interaction effects are stated in the box. Bars with different (unshared) alphabetic superscripts differ significantly (P<0.05) by Tukey’s honestly significantly different post hoc multiple-comparison test. Thus, A differs from BC but not from AB.
Figure 5
Figure 5
Cross-ApEn of paired cortisol-ACTH (feedback asynchrony) concentration profiles. ANCOVA yielded overall P<0.001 for combined effects of treatment and group. Subanalysis showed a drug treatment effect of P=0.053 (see Figure 4 format). ACTH-cortisol (feedforward) cross-ApEn data are given in Table 3.
See this image and copyright information in PMC

References

    1. RUBIN RT, MANDELL AJ. Adrenal cortical activity in pathological emotional states: a review. Am J Psychiatry. 1966;123(4):387–400. - PubMed
    1. CARROLL BJ, MARTIN FI, DAVIES B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J. 1968;3(613):285–287. - PMC - PubMed
    1. SACHAR EJ, HELLMAN L, FUKUSHIMA DK, GALLAGHER TF. Cortisol production in depressive illness. A clinical and biochemical clarification. Arch Gen Psychiatry. 1970;23(4):289–298. - PubMed
    1. NEMEROFF CB, WIDERLOV E, BISSETTE G, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984;226(4680):1342–1344. - PubMed
    1. UR E, DINAN TG, O’KEANE V, et al. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. Neuroendocrinol. 1992;56(4):533–538. - PubMed

Publication types

MeSH terms